Hepatitis C: Public health strategies

Journal of Hepatology, Supplement

Volumn 31, Issue 1, 1999, Pages 146-151

  Lavanchy, Daniel ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Blood transfusion; Drug use; Hepatitis C; Injection; Prevalence; Prevention; Public health; Transmission

Indexed keywords

BLOOD TRANSFUSION; CONFERENCE PAPER; DISEASE TRANSMISSION; HEPATITIS C; HUMAN; INFECTION PREVENTION; INFECTION RISK; PREVALENCE; PRIORITY JOURNAL; SEXUAL BEHAVIOR;

EID: 0033406823     PISSN: 01695185     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0168-8278(99)80392-4     Document Type: Conference Paper

References (48)

1. WHO. Global Surveillance and control of hepatitis C. J Med Virol 1999: 6: 35-47.
2. WHO. Hepatitis C: Global prevalence. Wkly Epidemiol Record 1997: 72: 341-344.
3. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ et al. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med 1992: 327: 1899-1905.
4. WHO. Hepatitis C. Wkly Epidemiol Record 1997: 72: 65-69.
5. Crofts N, Jolley D, Kaldor J, van Beek I, Vodak A. Epidemiology of hepatitis C virus infection among injecting drug users in Australia. J Epidemiol Community Health 1997: 51: 692-697.
6. Alter MJ, Hadler SC, Judson FN, Mares A, Alexander WJ, Hu PY et al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 1990: 264: 2231-2235.
7. Delage G, Infante-Rivard C, Chiavetta JA, Willems B, Pi D, Fast M. Risk factors for acquisition of hepatitis C virus infection in blood donors: results of a case-control study. Gastroenterology 1999: 116:893-899.
8. Alter MJ. Epidemiology of hepatitis C. Hepatology 1997: 26: 62S-65S.
9. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep 1998: 47: 1-39.
10. Mansell CJ, Locarnini SA. Epidemiology of hepatitis C in the East. Semin Liver Dis 1995: 15 (1): 15-32.
11. Aach RD, Stevens CE, Hollinger FB, Mosley JW, Peterson DA, Taylor PE et al. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N Engl J Med 1991: 325: 1325-1329.
12. Wang JT, Wang TH, Lin JT, Sheu JC, Sung JL, Chen DS. Hepatitis C virus in a prospective study of posttransfusion non-A, non-B hepatitis in Taiwan. J Med Virol 1990: 32: 83-86.
13. Donahue JG, Munoz A, Ness PM, Brown DE, Jr., Yawn DH, McAllister HA, Jr et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992: 327: 369-373.
14. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ: The risk of transfusion-transmitted viral infections. N Engl J Med 1996: 334: 1685-1690.
15. Suzuki K, Mizokami M, Lau JY, Mizoguchi N, Kalo K, Mizuno Y et al. Confirmation of hepatitis C virus transmission through needlestick accidents by molecular evolutionary analysis. J Infect Dis 1994: 170: 1575-1578.
16. Schvarcz R, Johansson B, Nystrom B, Sonnerborg A. Nosocomial transmission of hepatitis C virus. Infection 1997: 25: 7477.
17. Quinti I, Renganathan E, El Ghazzawi E, Divizia M, Sawaf G, Awad S et al. Seroprevalence of HIV and HCV infections in Alexandria, Egypt. Zentralbl Bakteriol 1995: 283: 239-244.
18. Kiyosawa K, Tanaka E, Sodeyama T, Yoshizawa K, Yabu K, Furuta K et al. Transmission of hepatitis C in an isolated area in Japan: community-acquired infection. The South Kiso Hepatitis Study Group. Gastroenterology 1994: 106: 1596-1602.
19. Frank C, Mohamed M, Strickland T, Arthur RR, El Khoby T, Abdel-Wahab Y et al. The role of parental antischistosomal therapy in the spread of hepatitis C virus in Egypt. 1999: in press.
20. WHO EPI. Two simple ways to use less vaccines. 1996.
21. Hamid SS, Farooqui B, Rizvi Q, Sultana T, Siddiqui AA. Risk of transmission and features of hepatitis C after needlestick injuries. Infect Control Hosp Epidemiol 1999: 20: 63-64.
22. Takagi H, Uehara M, Kakizaki S, Takahashi H, Takezawa J, Kabeya K et al. Accidental transmission of HCV and treatment with interferon. J Gastroenterol Hepatol 1998: 13: 238-243.
23. Mujeeb SA, Khatri Y, Khanani R. Frequency of parenteral exposure and seroprevalence of HBV, HCV, and HIV among operation room personnel. J Hosp Infect 1998: 38: 133-137.
24. Kaufmann M, Bode JC. HCV-Infektionsrisiko in medizinischen Berufen. Versicherungsmedizin 1997:49: 132-134.
25. Hofmann F, Michaelis M, Rieger MA, Hasselhorn HM, Berthold H. Zur arbeitsmedizinischen Bedeutung der Hepatitis C bei Beschäftigten im Gesundheitsdienst. Gesundheitswesen 1997: 59: 452-460."
26. Mizuno Y, Suzuki K, Mori M, Hayashi K, Owaki T, Hayashi H et al. Study of needlestick accidents and hepatitis C virus infection in healthcare workers by molecular evolutionary analysis. J Hosp Infect 1997: 35: 149-154.
27. Lanphear BP, Linnemann CG, Jr., Cannon CG, DeRonde MM, Pendy L, Kerley LM. Hepatitis C virus infection in Healthcare workers: risk of exposure and infection. Infect Control Hosp Epidemiol 1994: 15: 745-750.
28. Hepatitis C virus transmission from health care worker to patient. Commun Dis Rep CDR Wkly 1995: 5: 121.
29. Bruguera M. La transmisiôn de la hepatitis viral del medico al paciente, una circunstancia exceptional. Med Clin (Bare) 1997: 108: 537-538.
30. Gerberding JL. The infected health care provider. N EngI J Med 1996: 334: 594-595.
31. Mêle A, Sagliocca L, Manzillo G, Converti F, Amoroso P, Stazi MA et al. Risk factors for acute non-A, non-B hepatitis and their relationship to antibodies for hepatitis C virus: a case-control study. Am J Public Health 1994: 84: 1640-1643.
32. Alter MJ, Gerety RJ, Smallwood LA, Sampliner RE, Tabor E, Deinhardt F et al. Sporadic non-A, non-B hepatitis: frequency and epidemiology in an urban U.S. population. J Infect Dis 1982: 145: 886-893.
33. Alter MJ, Coleman PJ, Alexander WJ, Kramer E, Miller JK, Mandel E et al. Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. JAMA 1989: 262: 1201-1205.
34. Conry-Cantilena C, VanRaden M, Gibble J, Melpolder J, Shakil AO, Viladomiu L et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996: 334: 1691-1696.
35. Everhart JE, Di Bisceglie AM, Murray LM, Alter HJ, Melpolder JJ, Kuo G, et al. Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers. Ann Intern Med 1990: 112: 544-545.
36. Gordon SC, Patel AH, Kulesza GW, Barnes RE, Silverman AL. Lack of evidence for the heterosexual transmission of hepatitis C. Am J Gastroenterol 1992: 87: 1849-1851.
37. Tong MJ, Lai PPC, Hwang S-J. Evaluation of sexual transmission in patients with hepatitis C infection. Clin Virol Diagn 1995: 3: 39-47.
38. Westh H, Worm AM, Jensen BL, Kroon S, Kvinesdal B, Nielsen CM et al. Hepatitis C virus antibodies in homosexual men and intravenous drug users in Denmark. Infection 1993: 21: 115-117.
39. Marcellin P, Colin JF, Martinot-Peignoux M, Pham BN, Lefort V, Picault AB, Degott C et al. Hepatitis C virus infection in antiHIV positive and negative French homosexual men with chronic hepatitis: comparison of second- and third-generation anti-HCV testing. Liver 1993: 13: 319-322.
40. Donahue JG, Nelson KE, Munoz A, Vlahov D, Rennie LL, Taylor EL et al. Antibody to hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore, Maryland. Am J Epidemiol 1991: 134: 1206-1211.
41. Tor J, Llibre JM, Carbonell M, Muga R, Ribera A, Soriano V et al. Sexual transmission of hepatitis C virus and its relation with hepatitis B virus and HIV Br Med J 1990: 301: 1130-1133.
42. Thomas DL, Villano SA, Riester KA, Hershow R, Mofenson LM, Landesman SH et al. Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers. Women and Infants Transmission Study. J Infect Dis 1998: 177: 1480-1488.
43. Resti M, Azzari C, Lega L, Rossi ME, Zammarchi E, Novembre E, Vierucci A. Mother-to-infant transmission of hepatitis C virus. Acta Paediatr 1995: 84: 251-255.
44. Manzini P, Saracco G, Cerchier A, Riva C, Musso A, Ricotti E et al. Human immunodeficiency virus infection as risk factor for mother-to-child hepatitis C virus transmission: persistence of anti-hepatitis C virus in children is associated with the mother's anti-hepatitis C virus immunoblotting pattern. Hepatology 1995: 21: 328-332.
45. Zanetti AR, Tanzi E, Paccagnini S, Principi N, Pizzocolo G, Caccamo ML et al. Mother-to-infant transmission of hepatitis C virus. Lombardy Study Group on Vertical HCV Transmission. Lancet 1995: 345: 289-291.
46. Paccagnini S, Principi N, Massironi E, Tanzi E, Romano L, Muggiasca ML et al. Perinatal transmission and manifestation of hepatitis C virus infection in a high risk population. Pediatr Infect Dis J 1995: 14: 195-199.
47. Lin HH, Kao JH, Hsu HY, Ni YH, Chang MH, Huang SC et al. Absence of infection in breast-fed infants born to hepatitis C virus-infected mothers. J Pediatr 1995: 126: 589-591.
48. Ohto H, Okamoto H, Mishira S. Vertical transmission of hepatitis C virus. Lancet 1994: 331: 400.